Customers who bought this item also bought

• Protein Chaperones and Protection from Neurodegenerative Diseases. Wiley Series in Protein and Peptide Science
• Mass Spectrometry in Structural Biology and Biophysics. Architecture, Dynamics, and Interaction of Biomolecules. 2nd Edition. Wiley Series on Mass Spectrometry
• Atomic Force Microscopy in Liquid. Biological Applications
• Mass Spectrometry 2013: A Focus on Sales Growth
• CELL BIOLOGY ASSAYS
• Advances in Solid Oxide Fuel Cells VII. Ceramic Engineering and Science Proceedings. Volume 32, Issue 4
• World Fuel Cells - An Industry Profile with Market Prospects to 2010
• Advances in Chemical Physics. Experiments and Theory Single Molecule Biophysics. Volume 146
• Fluorescence Microscopy. From Principles to Biological Applications
• Transmembrane Dynamics of Lipids. Wiley Series in Protein and Peptide Science

An Immunotoxin for the Depletion of Autoreactive B Cells in MS. Edition No. 1

VDM Publishing House, August 2010, Pages: 80

The aim of the presented work was the design, production, and characterisation of a novel immunotoxin in the context of MS. Proteins were expressed in a prokaryotic and eukaryotic system, respectively. Stable producing 293T cell populations were established for the reference protein PLP that showed a good expression yield and a high purity after purification was obtained. This is the first time that a functional PLP fusion protein was expressed in 293T cells and purified from cell supernatant. The characterisation of the immunotoxin PLP-ETA comprised the verification of the functionality of the expressed protein in the context of the binding specifity and toxicity on a PLP- specific hybridoma cell line. This hybridoma cell line that served as a very feasible in vitro B cell model is the first step in the determination of the functionality of an immunotoxin. Documenting a high binding specifity and specific toxicity of this novel PLP based immunotoxin on a PLP- reactive hybridoma cell line, this work provides a contribution to the B cell specific therapies with immunotoxins in MS.

Sigrun, Klandt.
Sigrun Klandt, Dipl.-Ing.: Studium des Bioingenieurwesens an der FH Aachen. F